Proteomics International
Proteomics International is a pioneering medical technology company operating at the forefront of predictive diagnostics and bio-analytical services. The Company specialises in the area of proteomics – the industrial scale study of the structure and function of proteins. Proteomics International’s aim is to use its expertise in proteins to develop and commercialise diagnostic tests for chronic diseases where there is unmet medical need. Proteomics International was established in 2001, and is now recognised as a global leader in the field of proteomics. It operates from state-of-the art facilities at the Harry Perkins Institute of Medical Research in Perth, Western Australia.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Monitoring
- Market Focus:
- Globally (various continents)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
To maximise shareholder value in a financially sustainable manner, PI’s strategy is to:
1. Commercialise its test for diabetic kidney disease, PromarkerD.
PI is executing a stepped rollout of its flagship diagnostic test for diabetic kidney disease. Successful commercialisation of PromarkerD provides the opportunity to enjoy ongoing returns through licensing fees and royalty payments, which will grow as the test is adopted by more physicians and licensed into new geographic regions.
2. Research and develop other diagnostic tests.
PI is continuing to research potential diagnostic tests for endometriosis and Giardia, developing a pipeline of diagnostic tests which can be commercialised after PromarkerD. As these tests are commercialised, they will increase long-term revenue via licensing fees and royalty payments.
3. Provide Analytical Services.
The company’s Analytical Services provide fee-for-service revenue. This contributes to financially supporting the company’s commercialisation and research activities, until they start to pay dividends. They also offer synergies in access to markets and clients.
Proteomics International was established in 2001, and is now recognised as a global leader in the field of proteomics. It operates from state-of-the art facilities at the Harry Perkins Institute of Medical Research in Perth, Western Australia.
What is Proteomics?
Proteomics is the large-scale mapping of the structure and function of proteins.
- Unlike our genes, the protein make-up in our bodies differs from cell to cell and changes considerably over time. For example, a cancerous cell will have significantly different proteins to a healthy cell.
- The caterpillar and butterfly have exactly the same genes but differences in their proteins cause dramatic differences during the lifecycle.
Mission, Vision and Values
Values
Proteomics International is committed to maintaining the highest standards of integrity and quality of results whilst acting lawfully, ethically and responsibly.
- The Company will pursue operational and commercial excellence by using best practice approaches in our decision-making process focusing on continuous development, accountability and teamwork in all aspects of our business.
- In order to achieve these goals, we will ensure our employees and business partners have the appropriate skills and resources to perform their work effectively and efficiently and that all stakeholders (including investors, customers, suppliers and regulators) are aware of the Company’s values and our intention to uphold them.
- We will foster an open and supportive environment in all activities and relationships. A key attribute to this approach is maintaining responsible long-term management.
A critical component of Proteomics International’s strategy is maintaining its reputation for performing R&D and delivering its services in a reliable and credible manner. This is reflected in the strategic pillars of ground-breaking research and quality analytical services, and means that Proteomics International must put its reputation at the centre of everything it does.
The Code of Conduct is also underpinned by Proteomics International’s values to:
- Be open, honest and trustworthy and always do what we say we will do (Integrity and Accountability)
- Generate reliable data and results of the highest quality (Quality, Discipline and Excellence)
- Create novel products and services in areas of significant unmet need across medicine, veterinary health and agriculture (Innovation).
Commitment to values
The Company and its subsidiary companies are committed to conducting all of its business activities in accordance with the above stated values. The Board will ensure that all employees are given appropriate training on the Company’s values and the senior management group will continually demonstrate and reinforce such values in all interactions with staff.
We believe that our pursuit of these values will cement a positive reputation for the Company in the community as a reliable, responsible and ethical organisation.